Contribution of fibrinolysis to the physical component summary of the SF-36 after acute submassive pulmonary embolism

[1]  J. Giri,et al.  Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. , 2014, JAMA.

[2]  M. Sebbane,et al.  Fibrinolysis for patients with intermediate-risk pulmonary embolism. , 2014, The New England journal of medicine.

[3]  J. Kline,et al.  Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double‐blind, placebo‐controlled randomized trial , 2014, Journal of thrombosis and haemostasis : JTH.

[4]  J. Kline,et al.  Association of Body Mass Index With Increased Cost of Care and Length of Stay for Emergency Department Patients With Chest Pain and Dyspnea , 2014, Circulation. Cardiovascular quality and outcomes.

[5]  J. Kline,et al.  Rationale and methodology for a multicentre randomised trial of fibrinolysis for pulmonary embolism that includes quality of life outcomes , 2013, Emergency medicine Australasia : EMA.

[6]  S. Middeldorp,et al.  Quality of life after pulmonary embolism as assessed with SF-36 and PEmb-QoL. , 2013, Thrombosis research.

[7]  D. Coyle,et al.  Estimating quality of life in acute venous thrombosis. , 2013, JAMA internal medicine.

[8]  Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: rationale and design of the Pulmonary Embolism Thrombolysis (PEITHO) trial. , 2012, American heart journal.

[9]  H. Vliegen,et al.  Quality of life in long-term survivors of acute pulmonary embolism. , 2010, Chest.

[10]  J. Kline,et al.  Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure. , 2009, Chest.

[11]  J. Kline,et al.  Echocardiographic and functional cardiopulmonary problems 6 months after first-time pulmonary embolism in previously healthy patients. , 2007, European heart journal.

[12]  Gordon H Guyatt,et al.  Randomized trials stopped early for benefit: a systematic review. , 2005, JAMA.

[13]  Ronette L. Kolotkin,et al.  Quality of life and obesity , 2001, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[14]  C. Sherbourne,et al.  The RAND 36-Item Health Survey 1.0. , 1993, Health economics.